Publications

265 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Retigabine (Trobalt) for the adjunctive treatment of partial onset seizures with or without secondary generalisation in adults with epilepsy

As an adjunctive treatment for partial epilepsy, the therapeutic value of retigabine is comparable with that of gabapentin, ...

Report | 27-06-2011

Background report on assessing established medical science and medical practice in repetitive transcranial magnetic stimulation (rTMS) in depression

The existing literature provides insufficient data to be able to decide whether there is a place for rTMS in the standard of care ...

Report | 24-06-2011

Fluoride application on milk teeth

CVZ has carried out literature research into the question as to whether the professional application of fluoride to children who ...

Report | 24-06-2011

Physical therapy and exercise in cases of chronic arthritis

CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...

Report | 30-05-2011

Physical therapy and exercise in cases of osteoporosis

CVZ concludes that long-term physical therapy and exercise therapy for the indication “ vertebral fracture as a result of ...

Report | 30-05-2011

Physical therapy and exercise in cases of arthrosis

CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...

Report | 30-05-2011

Ticagrelor (Brilique) for the prevention of atherothrombotic events in adult patients with acute coronary syndromes

Patients treated with ticagrelor + ASA had a 22% reduced risk of all-cause mortality in comparison with patients treated with ...

Report | 23-05-2011

Calcium acetate-magnesium carbonate (OsvaRen) for hyperphosphatemia

The Committee maintains her verdict that the therapeutic value of OsvaRen is comparable with that calcium acetate.

Report | 23-05-2011

Ofatumumab (Arzerra) for Chronic Lymphatic Leukaemia

The orphan drug ofatumumab demonstrated a high objective response in patients who are refractory for fludarabine and alemtuzumab. ...

Report | 23-05-2011

Treating MS-CCSVI by cerebrospinal vein dilatation is medical science and practice

The basis for using venous angioplasty as a treatment for multiple sclerosis (MS), is the presumed pathophysiological mechanism ...

Report | 23-05-2011